文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

微小RNA与心脏转录后调控:心脏发育和疾病中的新角色

mA and cardiac posttranscriptional regulation: a novel player in heart development and disease.

作者信息

Li Donna, Li Deqiang, Jang Jihyun

机构信息

Center for Cardiovascular Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.

Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.

出版信息

Exp Mol Med. 2025 Sep 1. doi: 10.1038/s12276-025-01528-8.


DOI:10.1038/s12276-025-01528-8
PMID:40887502
Abstract

The growing body of research on cardiac epitranscriptomic factors has underscored their potential biological roles and impact on heart development and disease. While transcriptional and translational regulation of cardiac genes in the developing heart has been extensively studied, the potential roles of posttranscriptional regulation of cardiac mRNAs remain a significant gap in our understanding. In addition, discrepancies between transcriptomes and proteomes in both embryonic and adult hearts are well recognized, further suggesting an emerging regulatory role of the epitranscriptome in cardiac biology. Here we summarize the current understanding of mA machinery and associated RNA-binding proteins in the heart and discuss their impact on heart development. By identifying existing knowledge gaps, we aim to provide insights that may inform future research directions.

摘要

关于心脏表观转录组学因子的研究不断增加,这凸显了它们潜在的生物学作用以及对心脏发育和疾病的影响。虽然发育中心脏中基因的转录和翻译调控已得到广泛研究,但心脏mRNA转录后调控的潜在作用在我们的认知中仍存在重大空白。此外,胚胎心脏和成年心脏中转录组和蛋白质组之间的差异已得到充分认识,这进一步表明表观转录组在心脏生物学中具有新出现的调控作用。在这里,我们总结了目前对心脏中m⁶A机制及相关RNA结合蛋白的认识,并讨论它们对心脏发育的影响。通过识别现有的知识空白,我们旨在提供可能为未来研究方向提供参考的见解。

相似文献

[1]
mA and cardiac posttranscriptional regulation: a novel player in heart development and disease.

Exp Mol Med. 2025-9-1

[2]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[3]
RNA modifications in female reproductive physiology and disease: emerging roles and clinical implications.

Hum Reprod Update. 2025-3-27

[4]
Stage-specific DNA methylation dynamics in mammalian heart development.

Epigenomics. 2025-4

[5]
Genetic determinants of testicular sperm extraction outcomes: insights from a large multicentre study of men with non-obstructive azoospermia.

Hum Reprod Open. 2025-8-29

[6]
Translational Control in Cardiac Pathophysiology and Therapeutic Development: When mRNA Meets the Heart.

Int J Mol Sci. 2025-8-14

[7]
Improving sperm selection strategies for assisted reproduction through closing the knowledge gap in sperm maturation mechanics.

Hum Reprod Open. 2025-7-3

[8]
Exploring the mC epitranscriptome of mRNAs in breast cancer cells through genome engineering and long-read sequencing approaches.

Funct Integr Genomics. 2025-6-25

[9]
Fabricating mice and dementia: opening up relations in multi-species research

2025-2-25

[10]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2017-12-22

本文引用的文献

[1]
Loss of Methyltransferase and Hypomethylated m6A Sarcomere Transcripts Leading to Early-Onset Dilated Cardiomyopathy.

Circulation. 2025-6-10

[2]
Targeting Zfp36 to combat cardiac hypertrophy: Insights into ferroptosis pathways.

Clin Transl Med. 2025-3

[3]
YTHDF2 mediates the protective effects of MG53 on myocardial infarction injury via recognizing the m6A modification of MG53.

J Cardiothorac Surg. 2025-2-8

[4]
The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy.

Cell Death Dis. 2024-9-18

[5]
Methyltransferase METTL3 governs the modulation of SH3BGR expression through m6A methylation modification, imparting influence on apoptosis in the context of Down syndrome-associated cardiac development.

Cell Death Discov. 2024-9-6

[6]
The role of m6A in angiogenesis and vascular diseases.

iScience. 2024-5-23

[7]
WTAP-mediated mA modification of lncRNA Snhg1 improves myocardial ischemia-reperfusion injury via miR-361-5p/OPA1-dependent mitochondrial fusion.

J Transl Med. 2024-5-25

[8]
Endocardial HDAC3 is required for myocardial trabeculation.

Nat Commun. 2024-5-16

[9]
RNA binding proteins in cardiovascular development and disease.

Curr Top Dev Biol. 2024

[10]
Downregulation of Wtap causes dilated cardiomyopathy and heart failure.

J Mol Cell Cardiol. 2024-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索